Current through L. 2024, c. 185.
(a) A commercial feed or feed supplement, except a customer-formula feed, shall be accompanied by a label bearing the following information:(2) the product name and the brand name, if any, under which the commercial feed or feed supplement is distributed;(3) the guaranteed analysis as required by rule in section 329 of this title;(4) the common, usual name or collective term of each ingredient used in the manufacture of the commercial feed or feed supplement in descending order;(5) the name and principal mailing address of the manufacturer or the person responsible for distributing the commercial feed or feed supplement;(6) adequate directions for use for all commercial feeds or feed supplements containing drugs and for other feeds as the Secretary may require by rule as necessary for their safe and effective use; and(7) precautionary statements required to ensure the safe and effective use of the commercial feed or feed supplement.(b) A dosage form animal health product shall be accompanied by a label bearing the following information:(1) the net weight or count;(2) the product name and the brand name, if any, under which the dosage form animal health product is distributed;(3) the established name of each active ingredient and the amount of active ingredient per serving in descending order;(4) the established name of each inactive ingredient in alphabetical order or in descending order by predominance of the ingredient;(5) the name, city, and town of the manufacturer or the person responsible for distributing the dosage form animal health product or an e-mail address for the manufacturer or distributor;(6) adequate directions for use of the dosage form animal health product;(7) precautionary statements and warnings required to ensure the safe and effective use of the dosage form animal health product; and(8) structure-function claim stating the intended use of the dosage form animal health product.(c) Customer-formula feed shall be accompanied by a label, invoice, delivery slip, or other shipping document bearing the following information: (1) name and address of the manufacturer;(2) name and address of the purchaser;(4) the name of each commercial feed and each other ingredient used in the mixture;(5) adequate directions for use for all customer-formula feeds containing drugs and for such other feeds as the Secretary may require by rule to ensure their safe and effective use;(6) the direction for use and precautionary statements;(7) when a drug-containing product is used:(A) the purpose of the medication or a claim statement; and(B) the established name of each active drug ingredient and the level of each drug used in the final mixture; and(8) the guaranteed analysis as required by rule pursuant to section 329 of this title.(d) For purposes of labeling customer-formula feeds, the guaranteed analysis is not required when: (1) one or more of the ingredients are provided to the manufacturer by the final purchaser; or(2) the manufacturer uses a guaranteed analysis provided by the final purchaser as part of the specific instructions for blending a customer-formula feed.Amended by 2021 , No. 41, § 9, eff. 7/1/2021.Added 1985, No. 126 (Adj. Sess.), § 2; amended 1993, No. 13 , §§ 1, 2; 2003, No. 42 , § 2, eff. 5/27/2003.